Sobha Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:09 pm

Quick Insight

Sobha Ltd, with a current share price of 1,508 and a market cap of 16,128 Cr., appears overvalued with a high P/E ratio of 158, indicating potentially inflated market expectations. Despite a low ROE of 2.68% and ROCE of 6.44%, the company maintains a healthy OPM of 3% and a decent Net Profit of 95 Cr. However, its high borrowings of ₹1,183 Cr. and a P/BV ratio of 2.87x suggest a reliance on debt financing. With Promoters holding a significant 52.78% stake, investor confidence might be bolstered, but the relatively low FII and DII holdings warrant monitoring for increased institutional interest. In conclusion, Sobha Ltd's financial health and valuation metrics signal a cautious outlook for potential investors.

Competitors of Sobha Ltd

All Competitor Stocks of Sobha Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:20 am

Below is a detailed analysis of the quarterly data for Sobha Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 852.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,241.00 Cr. (Mar 2025) to 852.00 Cr., marking a decrease of 389.00 Cr..
• For Expenses, as of Jun 2025, the value is 828.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,147.00 Cr. (Mar 2025) to 828.00 Cr., marking a decrease of 319.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 70.00 Cr..
• For OPM %, as of Jun 2025, the value is 3.00%. The value appears to be declining and may need further review. It has decreased from 8.00% (Mar 2025) to 3.00%, marking a decrease of 5.00%.
• For Other Income, as of Jun 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 49.00 Cr., marking an increase of 19.00 Cr..
• For Interest, as of Jun 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 45.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 14.00 Cr..
• For Depreciation, as of Jun 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 19.00 Cr., marking a decrease of 37.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00%.
• For Net Profit, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 27.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.27. The value appears to be declining and may need further review. It has decreased from 3.82 (Mar 2025) to 1.27, marking a decrease of 2.55.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:01 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:19 pm

Below is a detailed analysis of the balance sheet data for Sobha Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 107.00 Cr.. The value appears strong and on an upward trend. It has increased from 95.00 Cr. (Mar 2024) to 107.00 Cr., marking an increase of 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,454.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,419.00 Cr. (Mar 2024) to 4,454.00 Cr., marking an increase of 2,035.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,183.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,940.00 Cr. (Mar 2024) to 1,183.00 Cr., marking a decrease of 757.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 11,461.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,228.00 Cr. (Mar 2024) to 11,461.00 Cr., marking an increase of 2,233.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 17,205.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13,682.00 Cr. (Mar 2024) to 17,205.00 Cr., marking an increase of 3,523.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,005.00 Cr.. The value appears strong and on an upward trend. It has increased from 946.00 Cr. (Mar 2024) to 1,005.00 Cr., marking an increase of 59.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 5.00 Cr..
• For Investments, as of Mar 2025, the value is 115.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 115.00 Cr..
• For Other Assets, as of Mar 2025, the value is 16,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 12,615.00 Cr. (Mar 2024) to 16,085.00 Cr., marking an increase of 3,470.00 Cr..
• For Total Assets, as of Mar 2025, the value is 17,205.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,682.00 Cr. (Mar 2024) to 17,205.00 Cr., marking an increase of 3,523.00 Cr..

Notably, the Reserves (4,454.00 Cr.) exceed the Borrowings (1,183.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Sobha Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 9.28. This value is within the healthy range. It has increased from 5.18 (Mar 24) to 9.28, marking an increase of 4.10.
• For Diluted EPS (Rs.), as of Mar 25, the value is 9.28. This value is within the healthy range. It has increased from 5.18 (Mar 24) to 9.28, marking an increase of 4.10.
• For Cash EPS (Rs.), as of Mar 25, the value is 17.25. This value is within the healthy range. It has increased from 13.43 (Mar 24) to 17.25, marking an increase of 3.82.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 426.47. It has increased from 265.07 (Mar 24) to 426.47, marking an increase of 161.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 426.47. It has increased from 265.07 (Mar 24) to 426.47, marking an increase of 161.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 377.67. It has increased from 326.52 (Mar 24) to 377.67, marking an increase of 51.15.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 39.13. This value is within the healthy range. It has decreased from 41.96 (Mar 24) to 39.13, marking a decrease of 2.83.
• For PBIT / Share (Rs.), as of Mar 25, the value is 30.73. This value is within the healthy range. It has decreased from 33.71 (Mar 24) to 30.73, marking a decrease of 2.98.
• For PBT / Share (Rs.), as of Mar 25, the value is 12.44. This value is within the healthy range. It has increased from 7.83 (Mar 24) to 12.44, marking an increase of 4.61.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.85. This value is within the healthy range. It has increased from 5.18 (Mar 24) to 8.85, marking an increase of 3.67.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.85. This value is within the healthy range. It has increased from 5.18 (Mar 24) to 8.85, marking an increase of 3.67.
• For PBDIT Margin (%), as of Mar 25, the value is 10.35. This value is within the healthy range. It has decreased from 12.85 (Mar 24) to 10.35, marking a decrease of 2.50.
• For PBIT Margin (%), as of Mar 25, the value is 8.13. This value is below the healthy minimum of 10. It has decreased from 10.32 (Mar 24) to 8.13, marking a decrease of 2.19.
• For PBT Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has increased from 2.39 (Mar 24) to 3.29, marking an increase of 0.90.
• For Net Profit Margin (%), as of Mar 25, the value is 2.34. This value is below the healthy minimum of 5. It has increased from 1.58 (Mar 24) to 2.34, marking an increase of 0.76.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.34. This value is below the healthy minimum of 8. It has increased from 1.58 (Mar 24) to 2.34, marking an increase of 0.76.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 15. It has increased from 1.95 (Mar 24) to 2.07, marking an increase of 0.12.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.96. This value is below the healthy minimum of 10. It has decreased from 9.71 (Mar 24) to 5.96, marking a decrease of 3.75.
• For Return On Assets (%), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 5. It has increased from 0.35 (Mar 24) to 0.54, marking an increase of 0.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has decreased from 0.28 (Mar 24) to 0.16, marking a decrease of 0.12.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has decreased from 0.76 (Mar 24) to 0.24, marking a decrease of 0.52.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.26. It has increased from 0.23 (Mar 24) to 0.26, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.25, marking an increase of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.29, marking an increase of 0.12.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 57.93 (Mar 24) to 0.00, marking a decrease of 57.93.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 22.34 (Mar 24) to 0.00, marking a decrease of 22.34.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 42.07 (Mar 24) to 0.00, marking a decrease of 42.07.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 77.66 (Mar 24) to 0.00, marking a decrease of 77.66.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 3. It has increased from 1.62 (Mar 24) to 2.14, marking an increase of 0.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 3. It has increased from 1.20 (Mar 24) to 1.48, marking an increase of 0.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 12,413.11. It has decreased from 14,938.35 (Mar 24) to 12,413.11, marking a decrease of 2,525.24.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.07. This value exceeds the healthy maximum of 3. It has decreased from 4.82 (Mar 24) to 3.07, marking a decrease of 1.75.
• For EV / EBITDA (X), as of Mar 25, the value is 29.67. This value exceeds the healthy maximum of 15. It has decreased from 37.54 (Mar 24) to 29.67, marking a decrease of 7.87.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.24. This value exceeds the healthy maximum of 3. It has decreased from 4.42 (Mar 24) to 3.24, marking a decrease of 1.18.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 42.06 (Mar 24) to 0.00, marking a decrease of 42.06.
• For Price / BV (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has decreased from 5.45 (Mar 24) to 2.87, marking a decrease of 2.58.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.24. This value exceeds the healthy maximum of 3. It has decreased from 4.42 (Mar 24) to 3.24, marking a decrease of 1.18.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness